Daniel Quirk

Chief Medical Officer, Head of Medical Affairs · Biogen

Biotechnology

Daniel Quirk is Biogen’s chief medical officer and head of medical affairs, following clinical gastroenterology and pharmaceutical medical leadership at Pfizer and Bristol Myers Squibb.

Last reviewed: Nov 2, 2026

Daniel Quirk

Chief Medical Officer, Head of Medical Affairs
Biogen

Last Reviewed: November 2, 2026

Executive Summary

Daniel Quirk is Biogen’s chief medical officer and head of medical affairs, following clinical gastroenterology and pharmaceutical medical leadership at Pfizer and Bristol Myers Squibb.

Career Highlights

  • Became Biogen chief medical officer and head of medical affairs on October 28, 2024.
  • Previously led worldwide medical affairs for immunology and neuroscience at Bristol Myers Squibb.
  • Served as associate chief of gastroenterology at Thomas Jefferson University Health Systems.

Professional Journey

Quirk practiced medicine before joining the pharmaceutical industry. As associate chief of gastroenterology at Thomas Jefferson University Health Systems in Philadelphia, he worked in patient care, clinical research and medical education. His medical training included Johns Hopkins Hospital and Massachusetts General Hospital.

He subsequently held leadership positions at Pfizer, most recently as vice president and medical category lead for inflammation and immunology in emerging markets.

At Bristol Myers Squibb, Quirk served as vice president of U.S. medical affairs for immunology and fibrosis and then senior vice president of U.S. medical affairs. He later led worldwide medical affairs for immunology and neuroscience as senior vice president.

Quirk became Biogen’s chief medical officer and head of medical affairs on October 28, 2024, reporting to head of development Priya Singhal. The appointment brought his clinical background and experience in U.S., emerging-market and worldwide medical affairs to Biogen’s medical organization.

Education

Quirk earned an M.D. from Brown University, an MPH from Harvard School of Public Health and an MBA from the Wharton School at the University of Pennsylvania. He trained at Johns Hopkins Hospital and Massachusetts General Hospital.